Target intelligence / Profile preview

Folliculogenesis-specific basic helix-loop-helix transcription factor (FIGLA)

Target
FIGLA
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) protein
01

Overview

Folliculogenesis-specific basic helix-loop-helix transcription factor (FIGLA) is a germ cell–specific transcription factor essential for early stages of oogenesis and folliculogenesis in female mammals[1][2][3][4]. FIGLA activates transcription of oocyte-restricted genes, including those encoding the zona pellucida proteins (ZP1, ZP2, ZP3), and represses genes normally expressed in male germ cells[1][3]. This ensures proper formation of primordial follicles and promotes oocyte survival. FIGLA is a central node within a transcriptional regulatory network, interacting and co-regulating with other oocyte-specific factors such as NOBOX, LHX8, SOHLH1, and SOHLH2, to coordinate gene programs necessary for oocyte differentiation and ovarian reserve maintenance[2][4]. Disruption of FIGLA—by mutation or loss of expression—leads to impaired folliculogenesis, oocyte apoptosis, primordial follicle loss, and is associated with human reproductive disorders including premature ovarian failure[1][2][3][4]. FIGLA is highly conserved in vertebrates, indicating a fundamental role across species in early folliculogenesis[3][4]. There are currently no drugs targeting FIGLA directly, and no noted safety concerns specific to therapeutic targeting; however, its essential role in ovarian biology means any perturbation may carry a significant risk of infertility[1].

Other names
Factor in the germline alphaBHLHC8FIGalphabHLHc8FigalphaClass C basic helix-loop-helix protein 8Folliculogenesis-specific basic helix-loop-helix proteinTranscription factor FIGaPOF6
02

Biological functions

Oocyte differentiationFolliculogenesis (primordial follicle formation)Regulation of oocyte-specific gene expression (activation of zona pellucida protein genes ZP1, ZP2, ZP3)Repression of male germ-cell-specific gene expressionMeiotic progressionOocyte survivalMaintenance of ovarian reserve
03

Disease associations

Premature ovarian failure / insufficiencyPrimary ovarian insufficiencyFemale infertility
04

Biomarkers

Loss of FIGLA expression or function is used as a biomarker for premature ovarian failure[1][3]Heterozygous mutation of FIGLA for patient stratification in reproductive disorders[3]

Beyond the preview

Go deeper on Folliculogenesis-specific basic helix-loop-helix transcription factor (FIGLA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folliculogenesis-specific basic helix-loop-helix transcription factor (FIGLA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call